{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:19:21Z","timestamp":1790129961568,"version":"4.0.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000900","name":"European Commission Joint Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.tibtech.2025.07.019","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T12:52:14Z","timestamp":1755694334000},"page":"289-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Strengthening the competitiveness of EU in vitro biotechnologies"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2200-1477","authenticated-orcid":false,"given":"Milena","family":"Mennecozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Piergiovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Selfa","family":"Aspiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2025.07.019_bb0005","series-title":"Advanced non-animal models in biomedical research: neurodegenerative diseases","author":"Witters","year":"2021"},{"key":"10.1016\/j.tibtech.2025.07.019_bb0010","series-title":"Advanced non-animal models in biomedical research: respiratory tract diseases","author":"Adcock","year":"2020"},{"key":"10.1016\/j.tibtech.2025.07.019_bb0015","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1038\/s41591-023-02362-z","article-title":"Researchers and regulators plan for a future without lab animals","volume":"29","author":"Moutinho","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.tibtech.2025.07.019_bb0020","series-title":"Initial recommendations on evaluation of data from the developmental neurotoxicity (DNT) in vitro testing battery - Series on Testing & Assessment No. 377\u2019","author":"OECD","year":"2023"},{"key":"10.1016\/j.tibtech.2025.07.019_bb0025","series-title":"Test No. 431: in vitro skin corrosion: reconstructed human epidermis (RHE) test method. OECD Guidelines for the Testing of Chemicals, Section 4","author":"OECD","year":"2025"},{"key":"10.1016\/j.tibtech.2025.07.019_bb0030","series-title":"3D cell culture market","author":"MarketsandMarkets","year":"2023"},{"key":"10.1016\/j.tibtech.2025.07.019_bb0035","series-title":"Cell based assays market","author":"MarketsandMarkets","year":"2025"},{"key":"10.1016\/j.tibtech.2025.07.019_bb0040","series-title":"High-throughput screening (HTS) market","author":"MarketsandMarkets","year":"2024"},{"key":"10.1016\/j.tibtech.2025.07.019_bb0045","doi-asserted-by":"crossref","first-page":"1237561","DOI":"10.3389\/fbioe.2023.1237561","article-title":"Organ chip research in Europe: players, initiatives, and policies","volume":"11","author":"da Silva","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.tibtech.2025.07.019_bb0050","series-title":"Code of practice on standardisation in the European Research Area \u2013 Commission recommendation","author":"European Commission, DG. for Research, and Innovation","year":"2023"},{"key":"10.1016\/j.tibtech.2025.07.019_bb0055","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1039\/D1LC00241D","article-title":"Standardisation needs for organ on chip devices","volume":"21","author":"Piergiovanni","year":"2021","journal-title":"Lab. Chip"},{"key":"10.1016\/j.tibtech.2025.07.019_bb0060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tifs.2023.02.006","article-title":"Implementing new approach methodologies (NAMs) in food safety assessments: strategic objectives and actions taken by the European Food Safety Authority","volume":"133","author":"Cattaneo","year":"2023","journal-title":"Trends in Food Science & Technology"},{"key":"10.1016\/j.tibtech.2025.07.019_bb0065","series-title":"The use of alternatives to testing on animals for the REACH Regulation","author":"European Chemicals Agency","year":"2023"}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016777992500280X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016777992500280X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T01:19:42Z","timestamp":1771031982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016777992500280X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S016777992500280X"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2025.07.019","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strengthening the competitiveness of EU in vitro biotechnologies","name":"articletitle","label":"Article Title"},{"value":"Trends in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tibtech.2025.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}